Apr 23, 2015Abbott, a global health-care company, needs to manage a large inventory of R&D materials that have a turnover similar to that of finished goods. This inventory can be problematic to control, as development materials are produced in smaller volumes and to specific formulations that may not be easily reproduced. Unlike standard inventory that can be reordered if misplaced or expired, R&D materials carry an inherent level of value that is difficult to q...
PREMIUM
THIS RECORDING OR VIDEO IS AVAILABLE TO PREMIUM MEMBERS. PLEASE LOG IN TO VIEW IT. IF YOU ARE NOT CURRENTLY A PREMIUM MEMBER, PLEASE CLICK HERE TO SIGN UP
